Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions


Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

Health Industry Forum outlines opportunities for investment and growth in Australia’s innovative medicines sector

Medicines Australia was pleased to attend the first Health Industry Forum, hosted by Industry Minister Ian Macfarlane MP, Health Minister Sussan Ley MP and Assistant Health Minister Fiona Nash MP at Parliament House today. The forum provided an opportunity for government and industry to work together to highlight opportunities for future investment and growth in…

View article· Thursday, 25 June 2015

Independent review of TGA provides sensible solutions to accelerate access to new Medicines

Medicines Australia welcomes the recommendations of an independent review into the Therapeutic Goods Administration (TGA) which, if adopted, will help to cut time delays and improve Australian’s access to new, innovative medicines. The Review examined the TGA’s regulatory framework and processes with a view to identifying areas of unnecessary red tape and opportunities to enhance…

View article· Thursday, 25 June 2015

Health Minister abandons Strategic Agreement with Medicines Australia – Medicines Industry stability and patient safety at risk

Medicines Australia is extremely disappointed with a last-minute decision by Health Minister Sussan Ley to abandon a Strategic Agreement, which casts a shadow over the future stability of the local medicines industry and also puts patient safety at risk. The purpose of the Agreement was to provide a level of stability and clarity for the…

View article· Tuesday, 23 June 2015

Grattan Institute misses the point, again

The Grattan Institute’s latest report seems to, again, miss the point. Enduring reforms to the Pharmaceutical Benefits Scheme (PBS) polices are achieving substantial savings for government and the Australian medicines industry is on the cusp of yet another; the biggest reform since 2007. “Measures currently before the Parliament will generate as much as $6.6 billion…

View article· Monday, 22 June 2015

Medicines Australia agrees to Federal Budget savings to secure a 5-Year Strategic Agreement

Medicines Australia, the peak body representing the innovative pharmaceutical industry, has agreed to sign a ‘Letter of Intent’ with the Australian Government for a 5-year strategic agreement. If finalised, the agreement will provide Australian patients and the medicines industry with a degree of stability and certainty in providing ongoing access to innovative medicines delivered through…

View article· Wednesday, 27 May 2015

Medicines Australia Welcomes New Chair and members of the Pharmaceutical Benefits Advisory Committee (PBAC)

Medicines Australia is pleased to welcome the appointment of Professor Andrew Wilson as incoming Chair of the Pharmaceutical Benefits Advisory Committee (PBAC). MA also welcomes the appointments of Dr Peter Grimison and Professor Jonathan Craig as members of the Committee. “I would like to congratulate all the new members on their appointments,” said Medicines Australia…

View article· Friday, 22 May 2015

New Appointments to Medicines Australia

Medicines Australia is pleased to announce two new senior appointments as part of its ongoing commitment to represent and promote Australia’s innovative medicines industry. James Boyce will take up the new position of Director of Communications and Government Relations and Dr Martin Snoke has been appointed as Manager of Policy and Research. James will start…

View article· Tuesday, 19 May 2015

Ensuring access to the best PBS

Australia’s innovative medicines industry has called on the Abbott Government to negotiate a five-year strategic agreement after it reached an in-principle deal with the Pharmacy Guild of Australia. Medicines Australia CEO, Tim James, said the sector that invents and manufactures medicines is seeking certainty from the Government following more than $3 billion in budget savings….

View article· Monday, 18 May 2015

Access to medicines at risk?

Australia’s peak medicines body has called on the Federal Government to clarify the extent of Budget cuts likely to affect essential and life-saving pharmaceuticals. Medicines Australia remains concerned that billions of dollars will be stripped from the Pharmaceutical Benefits Scheme in a move that will undermine patient access to breakthrough medicines. The organisation representing the…

View article· Tuesday, 12 May 2015

Hasty cuts may make it harder to access the new medicines that patients need

Health Minister, Sussan Ley’s announcement to list new medicines and vaccines on the PBS for cancer, blindness and shingles will be welcomed by many patients who have been waiting for these treatments to be available to them. Medicines Australia chief executive Tim James said “Listings of new medicines are supposed to happen. The PBS offers…

View article· Saturday, 9 May 2015

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


Are you doing @dryjuly? Great work by those who are - raising funds to improve lives of people living with cancer

RT @timothycjames: John Howard: PBS is sacrosanct and envy of other countries - and was only strengthened by #AUSFTA at @AmChamAU #AUSFTA10

RT @timothycjames: Member company of @MedicinesAus @Amgen sponsoring #AUSFTA10. DPM&C Secretary interviewing JWH and Bob Zoellick. http://t

Check out Medicines Australia’s submission to the Standing Committee on Health Inquiry into Hepatitis C in Australia

Hepatitis C report: A positive step forward that calls for strengthening of the Fourth National Hepatitis C Strategy

New PBO modelling shows the PBS is one of most sustainable parts of Budget spending #auspol

A lot of talk today on access to medicines. Here's our 2015 COMPARE report: Oz ranks 18/20 in OECD for access

Health Industry Forum outlines opportunities for investment and growth in Australia’s innovative medicines sector

Independent review of TGA provides sensible solutions to accelerate access to new Medicines

RT @LeanneWells63: At 'understanding biological & biosimilars worshop with @MedicinesAus. Complex area of emerging policy & practice. Educa…

Health Minister abandons Strategic Agreement with Medicines Australia

Grattan Institute misses the point, again

Help find answers for parents by funding & supporting vital research into stillbirth, SIDS & safe sleepn practices #RedNoseDay @RedNoseDayOz

Each day in AUS 2 people die from Motor neurone disease. Join the fight & raise awareness #MNDGlobalDay @mndaustralia

Well done Canberra! 96 CEOs including @timothycjames raised over $300k for homelessness in the ACT #CEOSleepoutAU